Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.
奥沙利铂、ATR抑制剂和抗PD-1抗体联合疗法可控制结肠癌的生长，诱导免疫区室的局部和全身变化，并保护小鼠免受肿瘤再次攻击
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010791
Fauvre Alexandra, Ursino Chiara, Garambois Veronique, Culerier Elodie, Milazzo Louis-Antoine, Vezzio-Vié Nadia, Jeanson Laura, Marchive Candice, Andrade Augusto Faria, Combes Eve, Atis Salima, Lossaint Gérald, Quenet François, Michaud Henri-Alexandre, Khellaf Lakhdar, Corbeau Ileana, Tosi Diego, Houede Nadine, Bonnefoy Nathalie, Sgarbura Olivia, Gongora Céline, Faget Julien
